KR20040074614A - 초본식물, 시스탄체 투부로사(스첸크) 위그트로부터추출되는 페닐에타노이드 글리코시드를 함유하는 의약제제, 그것의 제조방법, 및 그것의 사용 - Google Patents

초본식물, 시스탄체 투부로사(스첸크) 위그트로부터추출되는 페닐에타노이드 글리코시드를 함유하는 의약제제, 그것의 제조방법, 및 그것의 사용 Download PDF

Info

Publication number
KR20040074614A
KR20040074614A KR1020040010530A KR20040010530A KR20040074614A KR 20040074614 A KR20040074614 A KR 20040074614A KR 1020040010530 A KR1020040010530 A KR 1020040010530A KR 20040010530 A KR20040010530 A KR 20040010530A KR 20040074614 A KR20040074614 A KR 20040074614A
Authority
KR
South Korea
Prior art keywords
formulation
water
wight
schenk
polar solvent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020040010530A
Other languages
English (en)
Korean (ko)
Inventor
투펭페이
송지홍
레이리
Original Assignee
신파 파마세우티컬 코리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 신파 파마세우티컬 코리미티드 filed Critical 신파 파마세우티컬 코리미티드
Publication of KR20040074614A publication Critical patent/KR20040074614A/ko
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/64—Orobanchaceae (Broom-rape family)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/02—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating impedance
    • G01N27/04—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating impedance by investigating resistance
    • G01N27/12—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating impedance by investigating resistance of a solid body in dependence upon absorption of a fluid; of a solid body in dependence upon reaction with a fluid, for detecting components in the fluid
    • G01N27/125—Composition of the body, e.g. the composition of its sensitive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01M—TESTING STATIC OR DYNAMIC BALANCE OF MACHINES OR STRUCTURES; TESTING OF STRUCTURES OR APPARATUS, NOT OTHERWISE PROVIDED FOR
    • G01M3/00—Investigating fluid-tightness of structures
    • G01M3/02—Investigating fluid-tightness of structures by using fluid or vacuum
    • G01M3/04—Investigating fluid-tightness of structures by using fluid or vacuum by detecting the presence of fluid at the leakage point
    • G01M3/16—Investigating fluid-tightness of structures by using fluid or vacuum by detecting the presence of fluid at the leakage point using electric detection means
    • G—PHYSICS
    • G08—SIGNALLING
    • G08B—SIGNALLING SYSTEMS, e.g. PERSONAL CALLING SYSTEMS; ORDER TELEGRAPHS; ALARM SYSTEMS
    • G08B21/00—Alarms responsive to a single specified undesired or abnormal condition and not otherwise provided for
    • G08B21/02—Alarms for ensuring the safety of persons
    • G08B21/12—Alarms for ensuring the safety of persons responsive to undesired emission of substances, e.g. pollution alarms
    • G08B21/16—Combustible gas alarms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Electrochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Environmental & Geological Engineering (AREA)
  • Toxicology (AREA)
  • Business, Economics & Management (AREA)
  • Emergency Management (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Combustion & Propulsion (AREA)
  • Hematology (AREA)
KR1020040010530A 2003-02-18 2004-02-18 초본식물, 시스탄체 투부로사(스첸크) 위그트로부터추출되는 페닐에타노이드 글리코시드를 함유하는 의약제제, 그것의 제조방법, 및 그것의 사용 Ceased KR20040074614A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TW092103351 2003-02-18
TW092103351A TW200416036A (en) 2003-02-18 2003-02-18 Medicinal preparation containing phenylethanoid glycosides extracted from herbaceous plant, cistanche tubulosa (schenk.) wight, process of making the same, and uses of the same

Publications (1)

Publication Number Publication Date
KR20040074614A true KR20040074614A (ko) 2004-08-25

Family

ID=32847870

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020040010530A Ceased KR20040074614A (ko) 2003-02-18 2004-02-18 초본식물, 시스탄체 투부로사(스첸크) 위그트로부터추출되는 페닐에타노이드 글리코시드를 함유하는 의약제제, 그것의 제조방법, 및 그것의 사용

Country Status (6)

Country Link
US (2) US7087252B2 (https=)
JP (2) JP4926376B2 (https=)
KR (1) KR20040074614A (https=)
AU (1) AU2004200624B2 (https=)
CA (1) CA2457996C (https=)
TW (1) TW200416036A (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20150002576A (ko) * 2011-12-16 2015-01-07 신파 티엔리 파머슈티컬 컴퍼니 리미티드 (항저우) 아밀로이드 b 펩타이드 관련 질환 또는 이상을 예방 또는 치료하기 위한 약학적 조성물

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1736167B1 (en) * 2005-06-20 2018-03-21 I.R.B. Istituto Di Ricerche Biotecnologiche S.r.l. Extracts obtained from cell line cultures from Syringa vulgaris IRB-SV25/B (DMS:16857), their preparation and use
JP4965132B2 (ja) * 2006-01-27 2012-07-04 森下仁丹株式会社 更年期障害改善剤
AR059545A1 (es) * 2006-02-28 2008-04-09 Bayer Consumer Care Ag Combinacion de verbacosido y luteolina
CN100475189C (zh) * 2006-10-17 2009-04-08 王海龙 一种化妆品组合物及其制备方法和应用
JPWO2008093678A1 (ja) * 2007-01-29 2010-05-20 オリザ油化株式会社 ヒアルロニダーゼ阻害剤
US20080261896A1 (en) * 2007-04-11 2008-10-23 Sinphar Pharmaceutical Co., Ltd. Testosterone generating and metabolizing enhancer
JP2008280271A (ja) * 2007-05-09 2008-11-20 Oriza Yuka Kk 皮膚光老化予防剤
JP2009196895A (ja) * 2008-02-19 2009-09-03 Oriza Yuka Kk チロシナーゼ阻害剤
JP2009196908A (ja) * 2008-02-20 2009-09-03 Yomeishu Seizo Co Ltd リパーゼ阻害剤及び飲食品
JP2009263279A (ja) * 2008-04-25 2009-11-12 Oriza Yuka Kk エラスターゼ阻害剤
TWI486162B (zh) * 2010-06-16 2015-06-01 Sinphar Pharmaceutical Co Ltd 異類葉升麻苷或其醫藥學上可接受之鹽於抑制澱粉樣β肽生成、累積或聚集、以及製備預防或治療澱粉樣β肽相關疾病或狀況的藥物之用途
CN102329346A (zh) * 2011-05-31 2012-01-25 苏州派腾生物医药科技有限公司 一种从肉苁蓉中提取松果菊苷的方法
CN102304156B (zh) * 2011-06-24 2016-03-16 浙江爱诺药业股份有限公司 一种苯乙醇苷类成份及其制备方法和用途
CN102670436B (zh) * 2012-03-13 2013-09-25 珈侬生化科技(中国)有限公司 含管花肉苁蓉提取物的美白抗衰老化妆品及其制备方法
JP6151003B2 (ja) * 2012-10-26 2017-06-21 学校法人近畿大学 カンカニクジュヨウから得られる抗糖尿病剤、ヒト又は動物用医薬および機能性食品
US9339522B2 (en) * 2013-05-30 2016-05-17 Sinphar Pharmaceutical Co., Ltd. Method for regulating blood glucose level
WO2015154721A1 (zh) * 2014-04-10 2015-10-15 杏辉天力（杭州）药业有限公司 异类叶升麻苷衍生物及其制造方法与用途
MY190399A (en) 2014-05-08 2022-04-21 Access Business Group Int Llc A composition comprising cistanche and ginkgo extracts, the composition useful for improving memory of a subject
CN105111255A (zh) * 2015-08-12 2015-12-02 青海伊纳维康生物科技有限公司 一种肉苁蓉中松果菊苷和毛蕊花糖苷的提取分离方法
MY194024A (en) * 2016-01-12 2022-11-08 Sinphar Tian Li Pharmaceutical Co Ltd Hangzhou Use of cistanche tubulosa extract and isoacteoside in protection of muscles
CN108057038B (zh) * 2018-02-24 2020-09-01 上海中医药大学附属曙光医院 一种治疗肝纤维化的组合物及其应用
CN109369739A (zh) * 2018-11-16 2019-02-22 山东省药学科学院 一种具有脑保护活性的过山蕨植物提取物及其制备方法
CN110812375A (zh) * 2019-12-12 2020-02-21 中国海洋大学 一种老鼠簕中苯乙醇苷类提取物及其制备方法与作为抗肝损伤药物的应用
CN112608404B (zh) * 2020-12-01 2023-01-10 石河子大学 一种氨基功能化异质结构多孔微球及其制备方法和应用
CN112586515A (zh) * 2020-12-22 2021-04-02 长江绿银(无锡)科技有限公司 一种北美车前中提取化感物质和苯乙醇苷类化合物的方法
CN115778971B (zh) * 2023-01-08 2025-06-24 中国中医科学院中药研究所 一种包含肉苁蓉成分的药物组合物及其用途
CN116549466A (zh) * 2023-06-06 2023-08-08 上海泰楚生物技术有限公司 一种毛蕊花糖苷化合物在制备抗动脉血栓形成的药物中的应用
CN121242107B (zh) * 2025-12-04 2026-04-21 内蒙古自治区农牧业科学院 肉苁蓉茯茶饮品及其制备方法和货架期预测方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07223964A (ja) * 1994-02-01 1995-08-22 Du Pont Merck Pharmaceut Co ホスホリパーゼａ２阻害剤
JPH0940597A (ja) * 1994-12-13 1997-02-10 Natl Sci Council シナモフィリン及びその誘導体とこれらの製造方法及び血小板凝集抑制薬剤、気管弛緩薬剤、酸化防止剤及び血管弛緩薬剤

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20150002576A (ko) * 2011-12-16 2015-01-07 신파 티엔리 파머슈티컬 컴퍼니 리미티드 (항저우) 아밀로이드 b 펩타이드 관련 질환 또는 이상을 예방 또는 치료하기 위한 약학적 조성물

Also Published As

Publication number Publication date
JP2012021022A (ja) 2012-02-02
CA2457996C (en) 2009-08-04
AU2004200624B2 (en) 2006-02-16
TW200416036A (en) 2004-09-01
TWI331529B (https=) 2010-10-11
AU2004200624A1 (en) 2004-09-02
JP2004250449A (ja) 2004-09-09
US20040162246A1 (en) 2004-08-19
US7087252B2 (en) 2006-08-08
JP4926376B2 (ja) 2012-05-09
JP5352655B2 (ja) 2013-11-27
CA2457996A1 (en) 2004-08-18
US20060233896A1 (en) 2006-10-19

Similar Documents

Publication Publication Date Title
KR20040074614A (ko) 초본식물, 시스탄체 투부로사(스첸크) 위그트로부터추출되는 페닐에타노이드 글리코시드를 함유하는 의약제제, 그것의 제조방법, 및 그것의 사용
CN1268341C (zh) 来源于管花肉苁蓉的含有苯乙醇苷的制剂及其制备方法和用途
AU2003260985B2 (en) Extraction and purification method of active constituents from stem of Lonicera japonica Thunb., its usage for anti-inflammatory and analgesic drug
JP5955337B2 (ja) 苦丁茶冬青の葉の抽出方法、総サポニンおよびその使用
CN112716989A (zh) 一种芹菜籽提取物及其制备方法与应用
US8524291B2 (en) Anti-obesity product and its method of preparation
WO2008145064A1 (en) The method for a sequoyitol-containing extract obtaining from the genus of trifolium, sobyean and ginkgo biloba and use thereof
CN100453094C (zh) 中药复方通脉口服液有效部位的药物组合物及其制备方法
CN107854507B (zh) 一种从艾叶中提取黄酮类成分的方法
JP2000503686A (ja) 黄栢皮とオミナエシ植物の混合抽出物を含有するｃ型肝炎治療用製薬組成物
CN103156997B (zh) 一种治疗慢性肝病的中药有效部位组合物及其制备方法和应用
EP1498131B1 (en) Medicinal preparation containing phenylethanoid glycosides extracted from Cistanche tubulosa
CN119015372A (zh) 一种霍山石斛提取物及其提取方法和应用
TWI389701B (zh) 沉香屬果殼之萃取物及其於治療癌症之用途
CN103110680A (zh) 一种短葶飞蓬总酚酸的制备方法
CN1434042A (zh) 蒲黄提取物及其制备方法和用途
CN116354912A (zh) 一种化合物及其在作为或制备abcg2激动剂中的应用
CN119684378B (zh) 萱草花苷a及其制备方法和应用
CN116803402B (zh) 治疗糖尿病的中药组合物及制备方法
JP3161882B2 (ja) 丹参由来多糖類、その製造法および用途
CN114805465B (zh) 三萜类化合物及其制备方法和应用
CN106344601A (zh) Naucleamide G在制备抗炎药物中的应用
CN113264975A (zh) 一种刺梨根茎中提取的具有抗炎活性的提取物及其应用
CN102028726A (zh) 中药通关藤提取物及其制备方法和应用
KR20070088984A (ko) 독활 추출물을 함유하는 염증성 질환 및 치료에 유용한 약제

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 20040218

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20081028

Comment text: Request for Examination of Application

Patent event code: PA02011R01I

Patent event date: 20040218

Comment text: Patent Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20101022

Patent event code: PE09021S01D

AMND Amendment
E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20110628

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20101022

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

AMND Amendment
J201 Request for trial against refusal decision
PJ0201 Trial against decision of rejection

Patent event date: 20110728

Comment text: Request for Trial against Decision on Refusal

Patent event code: PJ02012R01D

Patent event date: 20110628

Comment text: Decision to Refuse Application

Patent event code: PJ02011S01I

Appeal kind category: Appeal against decision to decline refusal

Decision date: 20120427

Appeal identifier: 2011101005154

Request date: 20110728

PB0901 Examination by re-examination before a trial

Comment text: Amendment to Specification, etc.

Patent event date: 20110728

Patent event code: PB09011R02I

Comment text: Request for Trial against Decision on Refusal

Patent event date: 20110728

Patent event code: PB09011R01I

Comment text: Amendment to Specification, etc.

Patent event date: 20101216

Patent event code: PB09011R02I

B601 Maintenance of original decision after re-examination before a trial
PB0601 Maintenance of original decision after re-examination before a trial

Comment text: Report of Result of Re-examination before a Trial

Patent event code: PB06011S01D

Patent event date: 20110929

J301 Trial decision

Free format text: TRIAL DECISION FOR APPEAL AGAINST DECISION TO DECLINE REFUSAL REQUESTED 20110728

Effective date: 20120427

PJ1301 Trial decision

Patent event code: PJ13011S01D

Patent event date: 20120427

Comment text: Trial Decision on Objection to Decision on Refusal

Appeal kind category: Appeal against decision to decline refusal

Request date: 20110728

Decision date: 20120427

Appeal identifier: 2011101005154